These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1137 related articles for article (PubMed ID: 28716886)

  • 1. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.
    Erkkinen MG; Kim MO; Geschwind MD
    Cold Spring Harb Perspect Biol; 2018 Apr; 10(4):. PubMed ID: 28716886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.
    Boeve BF; Silber MH; Ferman TJ; Lucas JA; Parisi JE
    Mov Disord; 2001 Jul; 16(4):622-30. PubMed ID: 11481685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corpus callosum in neurodegenerative diseases: findings in Parkinson's disease.
    Wiltshire K; Foster S; Kaye JA; Small BJ; Camicioli R
    Dement Geriatr Cogn Disord; 2005; 20(6):345-51. PubMed ID: 16192724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein Levels in the Differential Diagnosis of Lewy Bodies Dementia and Other Neurodegenerative Disorders: A Meta-analysis.
    Mavroudis I; Petridis F; Chatzikonstantinou S; Kazis D
    Alzheimer Dis Assoc Disord; 2020; 34(3):220-224. PubMed ID: 32341240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of cerebral atrophy differ in different degenerative pathologies.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
    Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of Parkinson's disease and other neurodegenerative disorders.
    Koh J; Ito H
    Nihon Rinsho; 2017 Jan; 75(1):56-62. PubMed ID: 30566295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnostic challenge of corticobasal degeneration: distinction between clinical syndrome and pathology].
    Kellner O; Sabova K; Neumann M; Jung HH
    Fortschr Neurol Psychiatr; 2011 Nov; 79(11):660-7. PubMed ID: 22009274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential diagnosis of Parkinson's disease.
    Poewe W; Wenning G
    Eur J Neurol; 2002 Nov; 9 Suppl 3():23-30. PubMed ID: 12464118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging in aging and neurologic diseases.
    Risacher SL; Saykin AJ
    Handb Clin Neurol; 2019; 167():191-227. PubMed ID: 31753134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphological magnetic resonance imaging: its value for the diagnosis of neurodegenerative diseases].
    Hahn U; Schwarz J; Gratz S; Kaiser JW; Jarnig M; Förstl H
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S15-8. PubMed ID: 18437637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception.
    Moda F; Ciullini A; Dellarole IL; Lombardo A; Campanella N; Bufano G; Cazzaniga FA; Giaccone G
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):255. PubMed ID: 37919089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging biomarkers of neurodegenerative diseases and dementia.
    Risacher SL; Saykin AJ
    Semin Neurol; 2013 Sep; 33(4):386-416. PubMed ID: 24234359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of Gallyas-Braak stainings in pathologic diagnosis of neurodegenerative diseases].
    Wang L; Zhu M; Li X; Gui Q
    Zhonghua Nei Ke Za Zhi; 2002 Feb; 41(2):120-3. PubMed ID: 11940310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Neuropsychiatric Symptoms in Research Diagnostic Criteria for Neurodegenerative Diseases.
    Cummings J
    Am J Geriatr Psychiatry; 2021 Apr; 29(4):375-383. PubMed ID: 32819825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
    Seltman RE; Matthews BR
    CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
    Chouliaras L; Thomas A; Malpetti M; Donaghy P; Kane J; Mak E; Savulich G; Prats-Sedano MA; Heslegrave AJ; Zetterberg H; Su L; Rowe JB; O'Brien JT
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):651-658. PubMed ID: 35078917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.